Early Use of Remdesivir and Risk of Disease Progression in Hospitalized Patients With Mild to Moderate COVID-19

PURPOSE: Preliminary data suggest that remdesivir may influence the course of COVID-19 according to the duration of pre-admission symptoms. We aim to evaluate whether early use of remdesivir is associated with a reduced COVID-19 progression in a homogeneous cohort of patients with mild to moderate C...

Descripción completa

Detalles Bibliográficos
Autores principales: Falcone, Marco, Suardi, Lorenzo Roberto, Tiseo, Giusy, Barbieri, Chiara, Giusti, Lisa, Galfo, Valentina, Forniti, Arianna, Caroselli, Claudio, Della Sala, Leonardo, Tempini, Sara, Okoye, Chukwuma, Monzani, Fabio, Menichetti, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
COVID Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761549/
https://www.ncbi.nlm.nih.gov/pubmed/35120742
http://dx.doi.org/10.1016/j.clinthera.2022.01.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761549/
https://www.ncbi.nlm.nih.gov/pubmed/35120742
http://dx.doi.org/10.1016/j.clinthera.2022.01.007

Ejemplares similares